Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-036232
Filing Date
2021-02-10
Accepted
2021-02-10 16:03:24
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B3 d117132d424b3.htm 424B3 1813743
2 GRAPHIC g117132g03v16.jpg GRAPHIC 42170
3 GRAPHIC g117132g13a30.jpg GRAPHIC 128992
4 GRAPHIC g117132g13a40.jpg GRAPHIC 137639
5 GRAPHIC g117132g13c77.jpg GRAPHIC 134877
6 GRAPHIC g117132g14z95.jpg GRAPHIC 165557
7 GRAPHIC g117132g15k65.jpg GRAPHIC 108749
8 GRAPHIC g117132g16i22.jpg GRAPHIC 98342
9 GRAPHIC g117132g17u63.jpg GRAPHIC 149564
10 GRAPHIC g117132g23p99.jpg GRAPHIC 144075
11 GRAPHIC g117132g44i44.jpg GRAPHIC 70932
12 GRAPHIC g117132g67w31.jpg GRAPHIC 95674
13 GRAPHIC g117132g74p07.jpg GRAPHIC 133689
14 GRAPHIC g117132g81v00.jpg GRAPHIC 109571
  Complete submission text file 0001193125-21-036232.txt   3866361
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-252589 | Film No.: 21613735
SIC: 2834 Pharmaceutical Preparations